Basilea Pharmaceutica AG (BPMUF)
77.40
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Basilea Pharmaceutica Max Drawdown (5Y) : 55.70% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 55.70% |
| June 30, 2026 | 55.70% |
| May 31, 2026 | 55.70% |
| April 30, 2026 | 55.70% |
| March 31, 2026 | 55.70% |
| February 28, 2026 | 55.70% |
| January 31, 2026 | 55.70% |
| December 31, 2025 | 55.70% |
| November 30, 2025 | 55.70% |
| October 31, 2025 | 55.70% |
| September 30, 2025 | 55.70% |
| August 31, 2025 | 55.70% |
| July 31, 2025 | 55.70% |
| June 30, 2025 | 61.18% |
| May 31, 2025 | 63.66% |
| April 30, 2025 | 65.07% |
| March 31, 2025 | 69.22% |
| February 28, 2025 | 73.76% |
| January 31, 2025 | 73.76% |
| December 31, 2024 | 73.76% |
| November 30, 2024 | 73.76% |
| October 31, 2024 | 73.76% |
| September 30, 2024 | 73.76% |
| August 31, 2024 | 73.76% |
| July 31, 2024 | 74.23% |
| Date | Value |
|---|---|
| June 30, 2024 | 74.23% |
| May 31, 2024 | 74.23% |
| April 30, 2024 | 74.23% |
| March 31, 2024 | 74.23% |
| February 29, 2024 | 74.23% |
| January 31, 2024 | 74.23% |
| December 31, 2023 | 74.23% |
| November 30, 2023 | 74.23% |
| October 31, 2023 | 74.23% |
| September 30, 2023 | 74.23% |
| August 31, 2023 | 74.23% |
| July 31, 2023 | 74.23% |
| June 30, 2023 | 74.23% |
| May 31, 2023 | 74.23% |
| April 30, 2023 | 74.23% |
| March 31, 2023 | 74.23% |
| February 28, 2023 | 74.23% |
| January 31, 2023 | 74.23% |
| December 31, 2022 | 74.23% |
| November 30, 2022 | 74.23% |
| October 31, 2022 | 74.23% |
| September 30, 2022 | 74.23% |
| August 31, 2022 | 74.23% |
| July 31, 2022 | 74.23% |
| June 30, 2022 | 74.23% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Santhera Pharmaceuticals Holding AG | 98.31% |
| BeOne Medicines Ltd. | 69.96% |
| AC Immune SA | 89.55% |
| CRISPR Therapeutics AG | 85.11% |
| Idorsia Ltd. | 97.99% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -0.7670 |
| Beta (5Y) | 0.2896 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 25.19% |
| Historical Sharpe Ratio (5Y) | 0.0754 |
| Historical Sortino (5Y) | 0.1148 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 12.77% |